Ceres Announces Webcast of Fiscal Second Quarter 2016 Financial Results
Apr 11, 2016 20:30 pm UTC| Business
THOUSAND OAKS, Calif., April 11, 2016 -- Ceres, Inc. (Nasdaq:CERE), an agricultural biotechnology company focused on forage crops, today announced that it will report financial results for the second quarter of fiscal...
FreeSeas Inc. Announces Results of Special Meeting of Shareholders
Apr 11, 2016 20:30 pm UTC| Business
Athens, April 11, 2016 -- Athens, Greece, April 11, 2016 - FreeSeas Inc. (Nasdaq: FREE) (“FreeSeas” or the “Company”), a transporter of dry-bulk cargoes through the ownership and operation of a fleet of...
Nasdaq March 2016 Volumes, 1Q16 Est. Revenue Capture
Apr 11, 2016 20:30 pm UTC| Business
NEW YORK, April 11, 2016 -- Nasdaq (NASDAQ:NDAQ) today reported monthly volumes for March 2016, as well as quarterly volumes and estimated revenue capture for the quarter ending March 31, 2016, on its investor relations...
Wabash National Corporation Announces Earnings Release Date
Apr 11, 2016 20:20 pm UTC| Business
LAFAYETTE, Ind., April 11, 2016 -- Wabash National Corporation (NYSE:WNC) today announced it will conduct a conference call to review and discuss its first quarter results on Wednesday, April 27, 2016, at 10:00 a.m....
Pzena Investment Management, Inc. Announces First-Quarter 2016 Earnings Conference Call
Apr 11, 2016 20:15 pm UTC| Business
NEW YORK, April 11, 2016 -- Pzena Investment Management, Inc. (NYSE:PZN) today announced that it will hold a conference call to discuss the Company’s financial results and outlook at 10:00 a.m. ET, Wednesday, April 20,...
Apr 11, 2016 20:15 pm UTC| Business
NEW YORK, April 11, 2016 -- FXCM Inc.(NYSE:FXCM) today announced certain key customer trading metrics for March 2016 for its retail and institutional foreign exchange business. March 2016 Customer Trading Metrics from...
Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program
Apr 11, 2016 20:15 pm UTC| Business
CAMBRIDGE, Mass., April 11, 2016 -- Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR), a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating...